{
    "medicine_id": "ddfad10b4ef0ef24dd0877d5bd6d1594caf85003",
    "platform_id": "DB06742",
    "metadata": {
        "name": "Clanza CR 200 mg 1 Tablet film coated",
        "composition": "200 mg 1 Ambroxol",
        "clinical_particulars": {
            "therapeutic_indications": "Ambroxol is indicated for secretolytic therapy in bronchoplmonary diseaes with abnormal mucus secretion and transport It allows the mucus to be more easily cleared and ease a patient s breathing",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Ambroxol can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Ambroxol can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Ambroxol can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Ambroxol can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Haloperidol can be increased when it is combined with Ambroxol"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Ambroxol"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Ambroxol can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Ambroxol can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}